FDA IDE approval

PROVIDENCE, Rhode Island, USA, June 2, 2026 Signati Medical has achieved a significant regulatory milestone after receiving U.S. Food...

ACTON, Mass., May 4, 2026 Insulet Corporation has announced the enrollment of the first patient in its EVOLVE pivotal...

MIAMI, May 1, 2026 InspireMD, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its...

Seoul, South Korea | April 24, 2025 CGBIO has achieved a major regulatory milestone with the U.S. Food and...

BLOOMINGTON, Minn., USA, March 31, 2026 i-Lumen Scientific has received FDA Investigational Device Exemption (IDE) approval to initiate U.S....

Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...

NEW YORK, March 3, 2026 The global Implanted Brain-Computer Interface (BCI) Devices Market is projected to grow at a...

Andover, Massachusetts | February 9, 2026 — TransMedics Group has received full and unconditional Investigational Device Exemption (IDE) approval...